Literature DB >> 6948958

The expression of major histocompatibility antigens by human chorionic villi.

C A Sunderland, M Naiem, D Y Mason, C W Redman, G M Stirrat.   

Abstract

Frozen sections of human placentae taken at selected stages throughout gestation were stained with monoclonal antibodies to HLA-A, B, C and DR antigens, using an indirect immunoperoxidase technique. No staining of villous trophoblastic tissue was detected. Antibody to HLA-A, B, and C antigens clearly stained membranous elements of the villous stroma. Antibody to HLA-DR antigens stained rare, elongated cells of the villous stroma in the term placenta. Monoclonal antibodies to syncytiotrophoblast membrane were used as a control. This antigen distribution was confirmed by absorption of these monoclonal antibodies in an indirect radioimmunoassay. Adult spleen homogenate gave much stronger absorption than a trophoblast membrane preparation with antibodies to HLA-A, B, C or DR antigens. The opposite absorption pattern was observed with the anti-trophoblast monoclonal antibodies. Detergent solubilisation did not affect the absorption capacity of trophoblast membrane for HLA-A, B, C or DR antigens. Maternal antibody could be eluted from trophoblastic areas of term placental sections by washing at physiological pH, but this did not effect the binding of monoclonal antibodies. Thus the HLA antigens were not masked by preformed maternal alloantibody. These observations confirm that chorionic villous trophoblast does not express detectable HLA antigen. This may be the principal reason for the lack of rejection of the fetal allograft.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6948958     DOI: 10.1016/0165-0378(81)90048-6

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  28 in total

1.  Cell surface antigens of human trophoblast: definition of an apparently unique system with a monoclonal antibody.

Authors:  U W Mueller; C S Hawes; W R Jones
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

2.  Cells bearing class II MHC antigens in the human placenta and amniochorion.

Authors:  L Sutton; M Gadd; D Y Mason; C W Redman
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

3.  Cell populations in human early pregnancy decidua: characterization and isolation of large granular lymphocytes by flow cytometry.

Authors:  P M Starkey; I L Sargent; C W Redman
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

4.  Presentation of a soluble bacterial antigen and cell-surface alloantigens by large granular lymphocytes (LGL) in comparison with monocytes.

Authors:  C F Brooks; M Moore
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

5.  The expression of class II MHC gene products by fallopian tube epithelium in pregnancy and throughout the menstrual cycle.

Authors:  J N Bulmer; U Earl
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

6.  Differential expression of HLA class II antigens on human fetal and adult lymphocytes and macrophages.

Authors:  J A Edwards; D B Jones; P R Evans; J L Smith
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

7.  Leucocyte populations in ectopic tubal pregnancy.

Authors:  U Earl; D P Lunny; J N Bulmer
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

8.  Expression of class II MHC gene products by macrophages in human uteroplacental tissue.

Authors:  J N Bulmer; L Morrison; J C Smith
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

9.  Class I antigens of the major histocompatibility complex on cytotrophoblast of human chorion laeve.

Authors:  B L Hsi; C J Yeh; W P Faulk
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

10.  Limiting dilution analysis of the allo-MHC anti-paternal cytotoxic T cell response. II: Recurrent spontaneous abortion and the effect of immunotherapy.

Authors:  I T Manyonda; R S Pereira; J M Pearce; C E Sharrock
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.